Related Experiment Video
Updated: Jul 29, 2026
11:52
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
Published on: August 4, 2016
Gene expression-driven diagnostics and pharmacogenomics in cancer
1Veridex LLC, a Johnson & Johnson Company, 3210 Merryfield Row, San Diego, CA 92121, USA. ywang44@vrxus.jnj.com
Current Opinion in Molecular Therapeutics
|June 28, 2005
Summary
Microarray technology analyzes gene expression in tumors, aiding cancer classification and treatment. Standardization and validation are crucial for its clinical use in personalized oncology.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Microarray technology enables gene expression profiling of human tumors.
- Gene expression signatures are identified for tumor classification, prognosis, and therapy response.
- This technology can elucidate therapeutic mechanisms of action.
Purpose of the Study:
- To review studies on gene expression profiling for clinical applications.
- To highlight the potential of microarrays in supporting disease prognosis and therapy decisions.
- To discuss requirements for routine clinical implementation of microarrays.
Main Methods:
- Gene expression profiling using microarray technology.
- Analysis of clinically relevant tissue samples.
- Review of existing literature on microarray applications in oncology.
Main Results:
- Identification of gene expression patterns linked to tumor characteristics.
- Demonstration of microarrays' utility in predicting treatment outcomes.
- Highlighting the need for standardization and validation for clinical adoption.
Conclusions:
- Microarray-based gene expression profiling is a powerful tool in oncology.
- Standardization of techniques and extensive validation are essential for clinical integration.
- Further research is needed to fully realize the potential of microarrays in personalized cancer care.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...